Objective: We have previously demonstrated that myocardium is capable
of down-regulating its O-2 requirements and thus avoiding ischaemia wh
en O-2 supply is limited. The present study tested the hypothesis that
endogenous adenosine produced this protective response when O-2 suppl
y was decreased by moderate coronary hypoperfusion or moderate coronar
y hypoxaemia. Methods: In anaesthetised dogs, hearts were exposed by l
eft thoracotomy and instrumented for measuring intraventricular pressu
re and regional myocardial segment length. The left anterior descendin
g coronary artery was isolated, cannulated, and extracorporeally perfu
sed. Coronary O-2 supply was moderately reduced by lowering coronary p
erfusion pressure from 100 to 60 mmHg or by lowering coronary arterial
O-2 content by 50%. Hearts were treated with intracoronary infusions
of adenosine, adenosine deaminase to degrade endogenous adenosine or w
ith erythro-9-(2-hydroxy-3-nonyl)-adenine HCl (EHNA) to inhibit adenos
ine degradation by endogenous adenosine deaminase, during beta-adrener
gic stimulation with isoprenaline. Cardiac power in the left anterior
descending perfusion territory was indexed by the product of heart rat
e left ventricular peak systolic pressure percent systolic segment sho
rtening. O-2 utilisation efficiency was taken as the ratio of power in
dex/myocardial O-2 consumption. Results: Prior to a reduction in O-2 s
upply, isoprenaline did not alter O-2 utilisation efficiency. Intracor
onary adenosine increased O-2 utilisation efficiency during isoprenali
ne stimulation by 23% (P < 0.05). EHNA slightly increased O-2 utilisat
ion efficiency during isoprenaline stimulation (10%; P < 0.05); adenos
ine deaminase was without effect. When coronary perfusion pressure was
decreased, adenosine deaminase sharply lowered cardiac power and O-2
utilisation efficiency during isoprenaline stimulation, whereas EHNA a
ugmented isoprenaline-enhanced power and increased efficiency. During
hypoxaemia, adenosine deaminase lowered regional power bur not efficie
ncy during isoprenaline infusion; EHNA did not affect power but lowere
d O-2 consumption and increased efficiency. Myocardial lactate extract
ion and contractile function during isoprenaline stimulation were not
attenuated by reduced O-2 supply, indicating that myocardial ischaemia
did not occur under these conditions. Conclusion: Endogenous adenosin
e increases myocardial O-2 utilisation efficiency during beta-adrenerg
ic stimulation, and thus helps avert ischaemia when myocardial O-2 sup
ply is reduced.